AF0512-1mgSARS-COV-2 RBD Neutralizing Antibody (Human IgG1)1mg —说明书1份 保存条件: SARS-COV-2 RBD Neutralizing Antibody (Human IgG1) 4℃保存,至少一年有效。短期内不使用,推荐-20℃保存,-20℃可以保存更长时间。 注意事项: 如果本抗体用于Western blot (
SARS-CoV-2 N Protein Polyclonal antibody -20℃保存,Western一抗稀释液-20℃或4℃保存,一年有效。Western一抗稀释液优先推荐4℃保存,长期不使用可以考虑-20℃保存,但冻融可能会导致出现轻微的浑浊和少量不溶物。 注意事项: 如果本抗体用于Western blot (WB)、免疫荧光(IF)、免疫细胞化学(ICC)等实验,请注意回...
抗体名: Anti-SARS-CoV-2 NP/Nucleoprotein Monoclonal Antibody (1A164) 亚型: IgG1 是否单克隆: 是 免疫原: N/A 用途: 仅用于科研 宿主: Mouse 保质期: 1 year 应用范围: ELISA,IHC,WB 产地: France 标记物: Unconjugate 包装规格: 100 μg 品牌: AntibodySystem 抗原来源: N/A ...
产品类型 Antibody 全称 SARS-CoV-2 Spike Protein 别名 RBD, COVID-19 RBD, Spike, spike protein, SARS-CoV-2 Spike 计算分子量 141 kDa GenBank蛋白编号 NC_045512 基因名称 SARS-COV-2 Gene ID (NCBI) 43740568 RRID AB_2881223 偶联类型 Unconjugated 形式 Liquid 纯化方式 Antigen affinity purification...
The antigen detection is more difficult as compared to antibody detection, as the viral titer in sera and nasal swabs is often low. Sino Biological has released the world-first ELISA kits for the detection of SARS-CoV-2 N and S proteins. Several monoclonal antibodies developed by Sino Biologic...
Computationally restoring the potency of a clinical antibody against Omicron By demonstrating a computational approach to restore the clinical efficacy of a COVID-19 antibody, the potential to rapidly update clinical antibodies is explored. Thomas A. Desautels ...
View SARS-CoV-2 Envelope Antibody (MAB10894) validated in SARS-CoV-2. Additional non-catalog clones available.
武汉佰乐博生物(Biolab Reagents)由五位毕业于华中科技大学,华中农业大学,武汉大学等知名高校,且具有二十年工作经验的生命科学领域顶级研究者创立于2021年,凭借丰富的产品开发经验,利用全球领先的技术平台,引进和整合全球高品质的蛋白、抗体和试剂盒产品。目前,佰乐博生物作为法国AntibodySystem在亚洲的独家总代理,提供近30...
在SARS-CoV-2抗体研究中,目前主要有两种观点,一种倾向于对Fc段进行改造以减少潜在的ADE风险,如有研究者在Fc段引入LALA突变以降低Fc段的效应;另一种观点倾向于抗体会因抗体依赖的细胞介导的细胞毒性(antibody-dependent cell mediatedcytotoxicity,ADCC)和抗体...
Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants Here, the authors evaluate the neutralization susceptibilities of BA.2.86 and JN.1 and determine the structural basis for binding to the ACE2 receptor and monoclonal neutralizing antibodies, revealing...